Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$161.33 - $204.36 $161 - $204
-1 Reduced 2.38%
41 $8,000
Q4 2022

Feb 13, 2023

BUY
$191.53 - $236.82 $7,661 - $9,472
40 Added 2000.0%
42 $8,000
Q3 2022

Nov 14, 2022

SELL
$123.79 - $277.42 $123 - $277
-1 Reduced 33.33%
2 $1,000
Q2 2022

Aug 10, 2022

SELL
$93.97 - $143.33 $93 - $143
-1 Reduced 25.0%
3 $0
Q1 2022

May 13, 2022

SELL
$98.9 - $132.37 $98 - $132
-1 Reduced 20.0%
4 $1,000
Q4 2021

Feb 10, 2022

BUY
$110.64 - $159.4 $553 - $797
5 New
5 $1,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.